Skip to content

Quantitative Cardiac Parametric Mapping

Novel Magnetic Resonance Imaging Techniques for Quantitative Cardiac Parametric Mapping

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02855554
Acronym
Myomapping
Enrollment
240
Registered
2016-08-04
Start date
2014-06-20
Completion date
2026-12-31
Last updated
2025-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy, Myocarditis, Ischemic Heart Disease

Keywords

myocardial tissue characterization

Brief summary

The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.

Interventions

OTHERCardiac Magnetic Resonance (CMR) imaging techniques

Evaluation of clinical potential of fast quantitative myocardial tissue characterization using recently emerged CMRI techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject must be 18-90 years of age. * Subject must be previously diagnosed with or suspected to have one of the following conditions. * Myocardial ischemia or infarction (group 1) * Hypertrophic cardiomyopathy (group 2) * Infiltrative cardiomyopathy (group 3) * Myocarditis (group 4) * Subject must have been referred for a clinically indicated CMR.

Exclusion criteria

* Subject has any implanted device or condition in which an MR scan would be contraindicated. * Subject has an acute psychiatric disorder or is cognitively impaired. * Subject is using or is dependent on substances of abuse. * Subject is unwilling to comply with the requirements of the protocol. * Subject has previously entered this study. * Subject has an allergy against MRI contrast agents. * Subject is in acute unstable condition.

Design outcomes

Primary

MeasureTime frame
Clinical value of fast T1, T2, and T2* mapping of the left ventricle for the assessment of necrosis/scar, edema, and possible intramyocardial hemorrhage in patients with heart disease.2 years

Countries

United States

Contacts

Primary ContactMark Ghent, BA
ghent@musc.edu843-876-7148
Backup ContactJacob Rowe, BA
roweja@musc.edu843-876-4922

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026